Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TDS Pharm CoXKRX:464280 40 Days Payable is 35.84 as of Jun. 2026, which is 7% above its 10-year median of 33.57. GuruFocus rates XKRX:464280 with a GF Score™ of 40/100. The stock has 1 warning sign investors should review. Among 929 Drug Manufacturers companies, TDS Pharm Co ranks worse than 87.51% on this metric.
The historical rank and industry rank for TDS Pharm Co's Days Payable or its related term are showing as below:
XKRX:464280'
s Days Payable Range Over the Past 10 Years
Min: 29.4 Med: 33.57 Max: 37.03
Current: 32.26
During the past 6 years, TDS Pharm Co's highest Days Payable was 37.03. The lowest was 29.40. And the median was 33.57.
XKRX:464280's Days Payable is ranked worse than 87.51% of 929
companies
in the Drug Manufacturers industry
Industry Median: 88.13
vs XKRX:464280: 32.26
TDS Pharm Co's Days Payable
increased
from Jun. 2025 (31.01) to Jun. 2026 (35.84).
It may suggest that TDS Pharm Codelayed paying its suppliers.
The historical data trend for TDS Pharm Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:464280 vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, TDS Pharm Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TDS Pharm Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's Days Payable distribution charts can be found below:
* The bar in red indicates where TDS Pharm Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
TDS Pharm Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TDS Pharm Co (XKRX:464280) has a Days Payable of 35.84 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TDS Pharm Co and its competitors. This is near median its historical median of 33.57. Over the past decade, TDS Pharm Co's Days Payable has ranged from 29.40 to 37.03. According to the industry distribution chart, TDS Pharm Co ranks #813 out of 929 companies in the Drug Manufacturers industry, placing it in the top 87.5%.
Is TDS Pharm Co's Days Payable too high?
TDS Pharm Co's current Days Payable of 35.84 is near median its 10-year median of 33.57. Over the past 10 years, this metric has ranged from a low of 29.40 to a high of 37.03. The Drug Manufacturers industry median Days Payable is 88.13. TDS Pharm Co's value of 35.84 is 59.3% below this industry median. Based on the distribution chart, TDS Pharm Co ranks #813 out of 929 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, TDS Pharm Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does TDS Pharm Co's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TDS Pharm Co ranks #813 out of 929 companies for Days Payable. This places TDS Pharm Co in the lower half of its industry. The industry median Days Payable is 88.13. TDS Pharm Co's value of 35.84 is 59.3% below this benchmark. Historically, TDS Pharm Co's own Days Payable has ranged from 29.40 to 37.03 over the past decade. While the company's 10-year median is 33.57 vs. the industry median of 88.13, TDS Pharm Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.13, based on 929 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TDS Pharm Co's current Days Payable of 35.84 is 59.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on TDS Pharm Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TDS Pharm Co's current Days Payable is 35.84, which is near median its own 10-year median of 33.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TDS Pharm Co stock overvalued right now?
TDS Pharm Co (XKRX:464280) has a current Days Payable of 35.84. The current Days Payable is 35.84, which is near median its 10-year median of 33.57 and 59.3% below the Drug Manufacturers industry median of 88.13. TDS Pharm Co's overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For TDS Pharm Co (XKRX:464280), the current Days Payable is 35.84 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.
40GF Score
Get the complete analysis for XKRX:464280
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:464280 has been successfully added to your 
